Abstract 19086: Reducing Infarct Size by Protection of Ischemic Myocardium With Targeted Growth Factors
Introduction/HypothesisAfter AMI, patients suffer irreversible loss of heart function due to cardiomyocyte (CM) death and tissue scarring that may lead to heart failure. Growth factors can reduce CM apoptosis and scar size in preclinical studies but have poor drug-like qualities. Silver Creek Pharma...
Gespeichert in:
Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A19086-A19086 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!